This article is more than 5 years old. Information may no longer be current.
Hip arthroscopy may improve patient-reported outcomes in recreational golfers
Click Here to Manage Email Alerts
Recreational golfers who underwent hip arthroscopy for labral tears experienced significant improvement in patient-reported outcomes and a high rate of return to sport, according to results published in Orthopedics.
Benjamin G. Domb, MD, and colleagues recorded data on return to sport, surgical complications and secondary surgeries among 49 recreational golfers who underwent hip arthroscopy between August 2008 and February 2015. Researchers also collected measures for the modified Harris hip score, nonarthritic hip score, hip outcome score–sports specific subscale and VAS for pain at a minimum 2-year follow-up.
Overall, 81.6% of patients were included. Researchers found type 1 tears in 27.5% of patients, type 2 tears in 25% of patients and type 1 and type 2 tears in 47.5% of patients. Results showed significant improvements in the mean modified Harris hip score from 62.8 preoperatively to 79 postoperatively, the nonarthritic hip score from 61.6 preoperatively to 80.6 postoperatively, the hip outcome score–sports specific subscale score from 47.7 preoperatively to 64.4 postoperatively and the VAS from 5.8 preoperatively to 2.5 postoperatively. Researchers noted a mean patient satisfaction score of 7.8 and 90% of patients returned to golf postoperatively.
“Progress in surgical techniques in hip arthroscopy over recent years have made it possible to successfully address labral tears, femoroacetabular impingement and microinstability in the golfer’s hip,” Domb told Healio.com/Orthopedics. “Refinements including anatomic labral repair, spherical femoroplasty and capsular plication have allowed each of these pathologies to be treated respectively. The present-day study demonstrates a high rate of return to golf, significant improvements in function and high patient satisfaction in our cohort of golfers’ hips.” – by Casey Tingle
Disclosures: Domb reports he is a paid consultant for Arthrex, Stryker and Medacta; receives research support from Arthrex, Bref, Stryker and Medacta; and receives royalties from Arthrex, Orthomerica, DJO Global and Amplitude. Please see the full study for a list of all other authors’ relevant financial disclosures.
Click Here to Manage Email Alerts